Adenovirus Based Virotherapy Market Size

  • Report ID: 3118
  • Published Date: Nov 24, 2023
  • Report Format: PDF, PPT

Adenovirus Based Virotherapy Market Size

Adenovirus Based Virotherapy Market size is anticipated to reach USD 27 billion by the end of 2036, growing at a CAGR of 6% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of adenovirus based virotherapy was over USD 13 billion. The development and growth of the market is fueled by several factors, including ongoing clinical trials, regulatory approvals, and the commercialization of virotherapies. Positive results from clinical trials demonstrating the safety and efficacy of adenovirus-based virotherapy in treating certain types of cancer significantly drive market growth. Successful clinical outcomes contribute to regulatory approvals and increased industry interest. Along with these, escalating research & development concerned with adenovirus and surging demand for vector-based therapies are also projected to drive market growth in the coming years. Furthermore, rising government investments to spread awareness about early cancer detection are expected to provide ample growth opportunities to the market in the near future.

Adenovirus-based virotherapy involves the use of adenoviruses, which are common viruses that can cause respiratory and other infections in humans, as vectors to deliver therapeutic genes into cancer cells. These viruses are modified to selectively replicate in and destroy cancer cells while sparing normal, healthy cells. Obtaining regulatory approvals from agencies such as the FDA or EMA for adenovirus-based virotherapies is a critical factor for market growth. Regulatory clearance enables companies to bring their products to market and increases confidence among healthcare professionals and patients.


Adenovirus Based Virotherapy Market Overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3118
  • Published Date: Nov 24, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand for healthcare sector is the major factor driving the market growth.

The market size of adenovirus based virotherapy is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.

The major players in the market Amgen Inc., Merck & Co., Inc., Novartis International AG, Johnson & Johnson, Genelux Corporation, PsiOxus Therapeutics, Oncorus, Inc., and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample